好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Migraine Treatment with Rizatriptan and Usual Care Medications: An Open-Label Crossover Study
Headache and Pain
(-)
127
Authors/Disclosures
X. Henry Hu, MD, PhD (Merck & Co, Inc) No disclosure on file
Rachel Wurzman, PhD (University of Pennsylvania) No disclosure on file
No disclosure on file
No disclosure on file
Glen D. Solomon, MD (Dept. of Internal Medicine and Neurology) No disclosure on file
Roy H. Hamilton, MD, MS, FANA, FAAN Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
No disclosure on file
Harry B. Coslett, MD, FAAN (Univ of Pennsylvania) The institution of Dr. Coslett has received research support from NIDCD, NINDS, NIA. Dr. Coslett has received publishing royalties from a publication relating to health care.
John D. Medaglia, PhD (Drexel University) The institution of Dr. Medaglia has received research support from National Institutes of Health.
Ann C. McKee, MD (VA Boston) Dr. McKee has nothing to disclose.
No disclosure on file
No disclosure on file
Sudha Seshadri, MD, FAAN (Glenn Biggs Institute for Alzheimer'S and Neurodegenerative Diseases) Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.